TOP MEDICAL JOURNALS

Cardiovascular Diabetology is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.

Cardiovascular Diabetology aims to provide an address for all types of scientific communications related to the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome. The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. Large-vessel atherosclerosis can precede the development of diabetes, suggesting that rather than atherosclerosis being a complication of diabetes, both conditions may share genetic and environmental antecedents, a “common soil”. Insulin resistance and hyperinsulinemia lead to the development of the dysmetabolic syndrome, consisting of abdominal obesity, impaired fasting glucose, high triglyceride levels, low high-density lipoprotein levels and hypertension. Taking into consideration that this cluster of abnormalities is shared by both diabetes type 2 and atherosclerosis, the American Heart Association stated in 1999 that “diabetes is a cardiovascular disease”.

The worldwide prevalence of the dysmetabolic syndrome and diabetes mellitus - especially type 2, which makes up about 90% of the diabetic population - has continuously and rapidly increased during the last decades. The number of diabetic individuals is to double within 30 years, reaching 300 million in the year 2025. Premature atherosclerosis contributes to 75% of deaths among individuals with both type 1 and type 2 diabetes. Moreover, 25% of patients with newly diagnosed type 2 diabetes already have coronary artery disease. Diabetes mellitus has become a diagnosis of considerable and ominous importance in cardiovascular medicine, related to numerous hospital readmissions and high mortality and morbidity. Despite considerable improvements in the treatment of cardiovascular diseases, there is alarming evidence that patients with diabetes have hardly experienced any advantages from recent therapeutic achievements compared with their non-diabetic counterparts. Thus, a journal specifically dedicated to these issues is essential.

status :  OPEN ACCESS JOURNALS